No Data
Express News | Vivani Medical Shares up 5.6% on Plans to Begin Human Trial for Obesity Implant
Express News | Vivani Medical Inc: Expects to Initiate First Clinical Study Supporting Npm-115 Program in Q4 of 2024
Express News | EXCLUSIVE: Vivani Tells Benzinga 'The NPM-115 Clinical Program Will Consist of a Series of Studies Designed to Support the Development of Vivani's Miniature, 6-month GLP-1 NanoPortalTM Implant for Chronic Weight Management in Obese or Overweight Patients'
Express News | EXCLUSIVE: Vivani Medical Tells Benzinga 'Vivani Expects to Initiate the First Clinical Study Supporting the NPM-115 Program in the Fourth Quarter of 2024'
Express News | EXCLSUIVE: Vivani Medical Tells Benzinga Co. Provides Update On Clinical Development Plans For Miniature, Long-Term, GLP-1 Obesity Implant Program, NPM-115
EXCLUSIVE: Vivani Medical Outlines Plans To Kickstart First Clinical Study For Miniature GLP-1 Obesity Implant Program This Year
Vivani Medical Inc. (NASDAQ:VANI) expects to initiate the first clinical study for the NPM-115 program in Australia in the fourth quarter of 2024.The NPM-115 clinical program will evaluate the
103216711 : not moving at all, maybe the market dont like the news?![undefined undefined](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
TrytosaveabitOP 103216711: The volume is just awful! Hehehe